학술논문
Purpuric dermatosis and lymphocytic vasculopathy following SARS‐CoV‐2 vaccination: Report of two patients.
Document Type
Article
Source
Subject
*SARS-CoV-2
*VASCULAR diseases
*VACCINATION
*LEUKOCYTOCLASTIC vasculitis
*
*
*
Language
ISSN
1396-0296
Abstract
As mass immunization against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is being performed with vaccines on various platforms, a growing number of skin reactions have been attributed to these vaccines. Purpuric dermatosis and lymphocytic vasculopathy following SARS-CoV-2 vaccination: Report of two patients Besides the most commonly reported cutaneous adverse effects, several cases of immune-mediated reactions like immunobullous dermatoses are being reported following the Coronavirus disease 2019 (COVID-19) vaccination.1 Here, we describe two cases who developed purpuric dermatosis and lymphocytic vasculopathy following the administration of COVID-19 vaccines. [Extracted from the article]